Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Ross

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Kidney International Reports|July 19, 2019
New Insights into APOL1 and Kidney Disease in African Children and Brazilians Living With End-Stage Kidney DiseaseMichael J Ross
Expert Review of Clinical Immunology|May 19, 2010
Gene candidates in HIV-associated nephropathyMichael J Ross
Kidney International|May 16, 2014
Advances in the pathogenesis of HIV-associated kidney diseasesMichael J Ross
Nephron|October 11, 2021
The Impact of Chronic Kidney Disease on Outcomes of Patients with COVID-19 Admitted to the Intensive Care UnitMaureen Brogan, Michael J Ross
Current HIV Research|March 12, 2009
Murine models of Vpr-mediated pathogenesisAlexandra Snyder, Michael J Ross
Annual Review of Medicine|September 15, 2022
COVID-19 and Kidney DiseaseMaureen Brogan, Michael J Ross
Kidney International|May 15, 2017
ACE2 as therapy for glomerular disease: the devil is in the detailMichael J Ross, Masaomi Nangaku
Kidney International|May 24, 2023
Editing of APOL1 mRNA reduces APOL1 expression and activation of innate immunityHeidi Karttunen, Michael J Ross
Clinical Journal of the American Society of Nephrology : CJASN|August 10, 2017
Perspectives on the Nephrology Match for Fellowship ApplicantsMichael J Ross, Gregory Braden,
Kidney International|June 19, 2021
Re-energizing the kidney: targeting fatty acid metabolism protects against kidney fibrosisKimberly J Reidy, Michael J Ross
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Kidney International Reports|July 19, 2019
New Insights into APOL1 and Kidney Disease in African Children and Brazilians Living With End-Stage Kidney DiseaseMichael J Ross
Expert Review of Clinical Immunology|May 19, 2010
Gene candidates in HIV-associated nephropathyMichael J Ross
Kidney International|May 16, 2014
Advances in the pathogenesis of HIV-associated kidney diseasesMichael J Ross
Nephron|October 11, 2021
The Impact of Chronic Kidney Disease on Outcomes of Patients with COVID-19 Admitted to the Intensive Care UnitMaureen Brogan, Michael J Ross
Current HIV Research|March 12, 2009
Murine models of Vpr-mediated pathogenesisAlexandra Snyder, Michael J Ross
Annual Review of Medicine|September 15, 2022
COVID-19 and Kidney DiseaseMaureen Brogan, Michael J Ross
Kidney International|May 15, 2017
ACE2 as therapy for glomerular disease: the devil is in the detailMichael J Ross, Masaomi Nangaku
Kidney International|May 24, 2023
Editing of APOL1 mRNA reduces APOL1 expression and activation of innate immunityHeidi Karttunen, Michael J Ross
Clinical Journal of the American Society of Nephrology : CJASN|August 10, 2017
Perspectives on the Nephrology Match for Fellowship ApplicantsMichael J Ross, Gregory Braden,
Kidney International|June 19, 2021
Re-energizing the kidney: targeting fatty acid metabolism protects against kidney fibrosisKimberly J Reidy, Michael J Ross
Pageof 8